Discovery and Early Development of AVI-7537 and AVI-7288 for the Treatment of Ebola Virus and Marburg Virus Infections
Open Access
- 5 November 2012
- Vol. 4 (11) , 2806-2830
- https://doi.org/10.3390/v4112806
Abstract
There are no currently approved treatments for filovirus infections. In this study we report the discovery process which led to the development of antisense Phosphorodiamidate Morpholino Oligomers (PMOs) AVI-6002 (composed of AVI-7357 and AVI-7539) and AVI-6003 (composed of AVI-7287 and AVI-7288) targeting Ebola virus and Marburg virus respectively. The discovery process involved identification of optimal transcript binding sites for PMO based RNA-therapeutics followed by screening for effective viral gene target in mouse and guinea pig models utilizing adapted viral isolates. An evolution of chemical modifications were tested, beginning with simple Phosphorodiamidate Morpholino Oligomers (PMO) transitioning to cell penetrating peptide conjugated PMOs (PPMO) and ending with PMOplus containing a limited number of positively charged linkages in the PMO structure. The initial lead compounds were combinations of two agents targeting separate genes. In the final analysis, a single agent for treatment of each virus was selected, AVI-7537 targeting the VP24 gene of Ebola virus and AVI-7288 targeting NP of Marburg virus, and are now progressing into late stage clinical development as the optimal therapeutic candidates.Keywords
This publication has 56 references indexed in Scilit:
- Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectantProceedings of the National Academy of Sciences, 2011
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation studyThe Lancet, 2011
- Antisense Phosphorodiamidate Morpholino Oligomers Targeted to an Essential Gene InhibitBurkholderia cepaciaComplexThe Journal of Infectious Diseases, 2010
- Activation of Transgene-specific T Cells Following Lentivirus-mediated Gene Delivery to Mouse LungMolecular Therapy, 2010
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept studyThe Lancet Neurology, 2009
- A Morpholino Oligomer Targeting Highly Conserved Internal Ribosome Entry Site Sequence Is Able To Inhibit Multiple Species of PicornavirusAntimicrobial Agents and Chemotherapy, 2008
- Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomersVirology, 2008
- Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicityNucleic Acids Research, 2007
- Cellular Uptake of Antisense Morpholino Oligomers Conjugated to Arginine-Rich PeptidesBioconjugate Chemistry, 2004
- HIV Tat Peptide Enhances Cellular Delivery of Antisense Morpholino OligomersAntisense and Nucleic Acid Drug Development, 2003